Report copyright - 761034Orig1s000 - Food and Drug Administration · 1.1 Introduction Tecentriq (atezolizumab) is a humanized, Fc-engineered, IgG1 monoclonal antibody targeting programmed death-ligand
Please pass captcha verification before submit form